Current and future strategies for the treatment of malignant brain tumors. (Q35095713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Current and future strategies for the treatment of malignant brain tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

Maximiliano J Jiménez-Dalmaroni

2 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

author name string

R Cowen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

I K Williamson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

A David

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

X Yuan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

A Bigliari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

J C Williams

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

J Hu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

P R Lowenstein

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

Pharmacology & Therapeutics

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

71-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Epidemiologic study of primary intracranial neoplasms.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Dendritic cells: development, function and potential use for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Brain tumors induced in dogs by the Schmidt-Ruppin strain of Rous sarcoma virus. Neuropathological and immunological observations

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

IL-10 gene transfer to intracranial 9L glioma: tumor inhibition and cooperation with IL-2.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

1 reference

7 January 2021

Adeno-retroviral chimeric viruses as in vivo transducing agents.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

An epidemiological survey of primary tumours of the brain and spinal cord in South East Wales

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Transduction of a gene expression cassette using advanced generation lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Immune defects observed in patients with primary malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Targeted gene delivery by tropism-modified adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Transplacentar induction of neurogenic malignomas by 1,2-diethyl-hydrazine, azo-, and azoxy-ethane in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

High-efficiency Semliki Forest virus-mediated transduction in bovine adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Intercellular trafficking and protein delivery by a herpesvirus structural protein

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Engineering drug resistance in human cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

HSV as a gene transfer vector for the nervous system

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Diagnostic yield in CT-guided stereotactic biopsy of gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

CD28/B7 costimulation: a review

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392).

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A negative staining-carbon film technique for studying viruses in the electron microscope. II. Application to adenovirus type 5.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Critical issues in gene therapy for neurologic disease

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Large-scale production of retroviral vectors for systemic gene delivery

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA–liposome complexes

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy using HVJ-liposomes: the best of both worlds?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A “Distant” Bystander Effect of Suicide Gene Therapy: Regression of Nontransduced Tumors Together with a Distant Transduced Tumor

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A tale of two trials: selectively replicating herpesviruses for brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Costimulatory approaches to adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Site-specific integration by adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Poxvirus vectors: orphaned and underappreciated

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antiviral activity and mechanism of action of ganciclovir

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The glioblastoma multiforme in Georgia, 1977-1981.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Chromosomal effects of adeno-associated virus vector integration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Primary brain and spinal cord tumors induced by human adenovirus type 12 in hamsters

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Plasmid-driven formation of influenza virus-like particles

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Improved gene transfer efficiency in liver with vesicular stomatitis virus G-protein pseudotyped retrovirus after partial liver resection and thymidine kinase-ganciclovir pre-treatment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Incidence of brain tumours in two English counties: a population based study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastom

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Local endostatin treatment of gliomas administered by microencapsulated producer cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Chimeric viral vectors--the best of both worlds?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Folate, dysplasia, and cancer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Modulation of T-cell function by gliomas

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Morphological studies of rat brain tumors induced by N-nitrosomethylurea

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA).

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Noninvasive gene targeting to the brain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Nucleotide sequence and organization of the adeno-associated virus 2 genome

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Construction of Epstein-Barr virus-based expression vector containing mini-oriP.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Pharmacological strategies to increase the antitumor activity of methylating agents

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for ch

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Temozolomide as second-line chemotherapy for relapsed gliomas.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three cases

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Combined intra-arterial chemotherapy followed by radiation in astrocytomas

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Assessing response to chemotherapy in malignant glioma: the role of steroids.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Rat glioma cell death induced by cationic liposome-mediated transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50014-7

7 January 2021

10.1016/S0163-7258(03)00014-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667889 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference